Clinical Trials
13 trialsNCT06787053 2026-05-12
SELECT
University of Manchester
Recruiting
NCT05119335 2025-11-12
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NiKang Therapeutics, Inc.
Phase 1/2 Terminated
NCT06475261 2025-03-07
Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT06433063 2024-05-29
LuMISO
Ankara University
Phase NA Unknown
NCT06041555 2024-02-20
ISRAR
Hospices Civils de Lyon
Recruiting
NCT05702619 2023-01-27
HYPROGEN
The Christie NHS Foundation Trust
Unknown
NCT03365076 2023-01-09
EXIPOX
University Hospital of North Norway
Phase NA Terminated
NCT02584400 2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2 Terminated
NCT03098160 2017-10-30
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
Phase 1 Unknown
NCT00358397 2016-10-14
One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT00743379 2015-05-07
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
Threshold Pharmaceuticals
Phase 1/2 Completed
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed
NCT00090727 2006-11-02
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Novacea
Phase 1 Unknown